CXCL10 Signaling Contributes to the Pathogenesis of Arthritogenic Alphaviruses
Open Access
- 2 November 2020
- Vol. 12 (11), 1252
- https://doi.org/10.3390/v12111252
Abstract
Emerging and re-emerging arthritogenic alphaviruses, such as Chikungunya virus (CHIKV) and O’nyong nyong virus, cause acute and chronic crippling arthralgia associated with inflammatory immune responses. Approximately 50% of CHIKV-infected patients suffer from rheumatic manifestations that last 6 months to years. However, the physiological functions of individual immune signaling pathways in the pathogenesis of alphaviral arthritis remain poorly understood. Here, we report that a deficiency in CXCL10, which is a chemoattractant for monocytes/macrophages/T cells, led to the same viremia as wild-type animals, but fewer immune infiltrates and lower viral loads in footpads at the peak of arthritic disease (6–8 days post infection). Macrophages constituted the largest immune cell population in footpads following infection, and were significantly reduced in Cxcl10−/− mice. The viral RNA loads in neutrophils and macrophages were reduced in Cxcl10−/− compared to wild-type mice. In summary, our results demonstrate that CXCL10 signaling promotes the pathogenesis of alphaviral disease and suggest that CXCL10 may be a therapeutic target for mitigating alphaviral arthritis.Keywords
This publication has 53 references indexed in Scilit:
- Pharmacologic Inhibition of CXCL10 in Combination with Anti-malarial Therapy Eliminates Mortality Associated with Murine Model of Cerebral MalariaPLOS ONE, 2013
- Interferon Response Factors 3 and 7 Protect against Chikungunya Virus Hemorrhagic Fever and ShockJournal of Virology, 2012
- A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritisVaccine, 2011
- The Acute Phase of Chikungunya Virus Infection in Humans Is Associated With Strong Innate Immunity and T CD8 Cell ActivationThe Journal of Infectious Diseases, 2010
- Chikungunya Virus Arthritis in Adult Wild-Type MiceJournal of Virology, 2010
- Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophagesJCI Insight, 2010
- Type I IFN controls chikungunya virus via its action on nonhematopoietic cellsThe Journal of Experimental Medicine, 2010
- A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infectionNature Medicine, 2010
- Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritisThe Journal of Experimental Medicine, 2007
- An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–1953Transactions of the Royal Society of Tropical Medicine and Hygiene, 1955